Comparative efficacy and safety of biosimilar ‐infliximab and originator‐infliximab in combination with methotrexate in patients with active rheumatoid arthritis: a meta‐analysis of randomized controlled trials

International Journal of Rheumatic Diseases, EarlyView.

Source: APLAR Journal of Rheumatology - April 19, 2018 Category: Rheumatology Authors: Sang ‐Cheol Bae , Young Ho Lee Source Type: research